What is ATTO's current stock price?

ATTO (Attovia Therapeutics, Inc.) is currently trading at $20.96 with a market cap of $901.9M.

What sector is Attovia Therapeutics, Inc. in?

Attovia Therapeutics, Inc. (ATTO) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

ATTO Attovia Therapeutics, Inc.

NASDAQHealthcare

$20.96+0.77%ClosedMarket Cap: $901.9M

As of 2026-08-24

Why ATTO matters now

Attovia Therapeutics, Inc. (ATTO) is a US stock in Healthcare. The latest InvestLog snapshot shows $20.96 with +0.77% on the session and $901.9M in market capitalization.

The latest indexable market news headline is "Meet Attovia: The Clinical-Stage Biotech That Aims to Stop Chronic Itch at the Source" from 24/7 Wall Street.

Latest News

Meet Attovia: The Clinical-Stage Biotech That Aims to Stop Chronic Itch at the Source24/7 Wall Street · 2026-08-17

Attovia Therapeutics (NASDAQ:ATTO) Director Acquires $1,785,000.00 in StockDefense World · 2026-08-17

Attovia Therapeutics (NASDAQ:ATTO) Major Shareholder Global Strategic Fund Venbio Purchases 382,352 Shares of StockDefense World · 2026-08-11

Attovia Therapeutics (NASDAQ:ATTO) Major Shareholder Redmile Group, Llc Purchases 200,000 SharesDefense World · 2026-08-11

Attovia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional SharesGlobeNewsWire · 2026-08-06

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

NASDAQ

Beta

0.00

A clinical-stage biopharmaceutical company developing biotherapeutics for immune-mediated diseases using its ATTOBODY biologics platform. The company's lead candidate, ATTO-1310, targets interleukin-31 (IL-31), known as the 'itch cytokine,' for the treatment of chronic pruritic diseases including atopic dermatitis. Its pipeline also includes multi-specific candidates for other inflammatory diseases.